Cargando…
Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents
PURPOSE: The purpose of this study was to evaluate overall survival after systemic therapy, largely chemotherapy, in patients with small cell or non-small cell lung cancer and brain metastases. After completion of systemic therapy, some patients received planned brain irradiation, while others were...
Autores principales: | Nieder, Carsten, Aanes, Siv G., Haukland, Ellinor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508211/ https://www.ncbi.nlm.nih.gov/pubmed/35020043 http://dx.doi.org/10.1007/s00432-022-03919-0 |
Ejemplares similares
-
30-day mortality in patients treated for brain metastases: extracranial causes dominate
por: Nieder, Carsten, et al.
Publicado: (2022) -
Days at home in the last three months of life: patterns-of-care analysis in patients with non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2023) -
Palliative non-small cell lung cancer treatment and end-of-life care stratified by sex and childlessness: an important interplay in unmarried patients?
por: Nieder, Carsten, et al.
Publicado: (2022) -
Does Time between Imaging Diagnosis and Initiation of Radiotherapy Impact Survival after Whole-Brain Radiotherapy for Brain Metastases?
por: Nieder, Carsten, et al.
Publicado: (2013) -
Presence of Brain Metastases at Initial Diagnosis of Cancer: Patient Characteristics and Outcome
por: Nieder, Carsten, et al.
Publicado: (2019)